We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Verici Dx plc,today announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific, to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection.
As confusing as it may be for health insurance buyers and taxpayers, the latest moves on the Affordable Care Act (ACA) don't spell its imminent collapse, according to experts who follow the law.
Over one million Americans are hospitalized for heart failure (HF) each year. This results in a poor prognosis for patients and places a significant financial burden on the US healthcare system.